Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Award notice |
| Buyer: | The Royal Marsden NHS Foundation Trust |
| Main Category: | Goods |
| Procurement Method: | Direct award |
| Method Rationale: | RMH already have the equipment that is compatible with this assay. Furthermore the Skyline MMprofiler is currently the only GEP test that has achieved both CE-IVD and UKCA marking. CE-IVD approval in Europe enables us to deliver this test for private patients across the UK and Europe. Its adoption will enhance risk assessment accuracy, improve patient outcomes, and optimise resource utilisation within the Trust. |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | Not specified |
| Release Date: | 19 March 2026 |
| Application Deadline: | — |
| Contract Start Date: | — |
| Contract End Date: | — |
| Contract Duration: | NaN years |
| Procurement ID (OCID): | ocds-h6vhtk-066f3a |
| Notice Reference: | 025295-2026 |
All 2 notices for this procurement, oldest first.
MMprofiler
MMprofiler
View Original Notice
Access the full notice on the official portal
Awarded to
| Award value: | £635,890 |
| Award status: | Pending |
Supply of MMprofiler assay for gene expression profiling.
Published contracts in the last 12 months
29
total contracts
£7.0m
total value
£1,160,237
average contract size
Typical categories
Prior Information Notice (PIN) for an innovation partnership to develop Artificial Intelligence (AI) in mammography
The Royal Marsden NHS Foundation Trust · WAC-148670
The Royal Marsden NHS Foundation Trust Magazine Design and Print
The Royal Marsden NHS Foundation Trust · WAC-148847
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →